Idelalisib monotherapy and durable responses in patients with relapsed or refractory small lymphocytic lymphoma (SLL)

被引：0
|
作者：
Gopal, A. [1 ]
Davies, A. J. [2 ]
Flinn, I. [3 ]
Ghia, P. [4 ,5 ]
Goy, A. [6 ]
Salles, G. [7 ]
Abella, S. [8 ]
Philip, B. [8 ]
Sorenson, B. [8 ]
Wagner-Johnston, N. [9 ]
机构：
[1] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA
[2] Univ Southampton, Canc Sci Unit, Salisbury, Wilts, England
[3] Sarah Cannon Res Inst, Hematol Malignancies Res Program, Nashville, TN USA
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] IRCCS Ist Sci San Raffaele, Milan, Italy
[6] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[7] Univ Lyon 1, Hosp Civils Lyon, Pierre Benite, France
[8] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[9] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2016年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
245
引用
下载
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA (SLL)
    Davies, A. J.
    Gopal, A. K.
    Flinn, I. W.
    Ghia, P.
    Goy, A.
    Abella-Dominicis, E.
    Philip, B.
    Sorenson, B.
    Salles, G. A.
    Wagner-Johnston, N. D.
    HAEMATOLOGICA, 2016, 101 : 757 - 757
  • [2] Idelalisib Monotherapy and Durable Responses in Patients with Relapsed or Refractory Small Lymphocytic Lymphoma (SLL)
    Gopal, Ajay K.
    Davies, Andrew John
    Flinn, Ian W.
    Ghia, Paolo
    Goy, Andre
    Salles, Gilles A.
    Abella, Steve
    Philip, Betsy
    Sorenson, Bess
    Wagner-Johnston, Nina D.
    BLOOD, 2015, 126 (23)
  • [3] Idelalisib Monotherapy and Durable Responses in Patients with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
    Martin, Peter
    Armas, Armando
    Gopal, Ajay K.
    Gyan, Emmanuel
    Wagner-Johnston, Nina D.
    Walewski, Jan
    Abella, Steve
    Ye, Wei
    Philip, Betsy
    Sorenson, Bess
    de Vos, Sven
    BLOOD, 2015, 126 (23)
  • [4] Idelalisib monotherapy and durable responses in patients with relapsed or refractory marginal zone lymphoma (MZL)
    Martin, P.
    Armas, A.
    Gopal, A.
    Gyan, E.
    Wagner-Johnston, N.
    Walewski, J.
    Abella, S.
    Ye, W.
    Philip, B.
    Sorenson, B.
    de Vos, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 100 - 100
  • [5] DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA (MZL)
    Gyan, E.
    Martin, P.
    Armas, A.
    Gopal, A. K.
    Wagner-Johnston, N. D.
    Abella-Dominicis, E.
    Ye, W.
    Philip, B.
    Sorenson, B.
    Walewski, J.
    de Vos, S.
    HAEMATOLOGICA, 2016, 101 : 757 - 758
  • [6] Idelalisib monotherapy and durable responses in patients with relapsed or refractory Waldenstroms Macroglobulinemia (WM)
    Coutre, Steven
    Leonard, John
    Flowers, Christopher
    Davies, Andrew John
    Jurczak, Wojciech
    Byrd, John C.
    Spurgeon, Stephen Edward Forbes
    Peterman, Sissy
    Holes, Leanne
    Cho, Yoonjin
    Sorenson, Bess
    Godfrey, Wayne Russell
    Gopal, Ajay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM MACROGLOBULINEMIA
    Zinzani, P. L.
    Ghia, P.
    Coutre, S.
    Leonard, J.
    Flowers, C.
    Davies, A.
    Jurczak, W.
    Byrd, J. C.
    Spurgeon, S.
    Peterman, S.
    Holes, L.
    Cho, Y.
    Sorensen, B.
    Godfrey, W. R.
    Gopal, A. K.
    Carella, A. M.
    HAEMATOLOGICA, 2015, 100 : 38 - 39
  • [8] Idelalisib monotherapy results in durable responses in patients with relapsed or refractory Waldenstrom's macroglobulinemia (WM)
    Coutre, S.
    Leonard, J.
    Flowers, C.
    Davies, A.
    Jurczak, W.
    Byrd, J.
    Spurgeon, S.
    Peterman, S.
    Holes, L.
    Cho, Y.
    Sorenson, B.
    Godfrey, W.
    Gopal, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 102 - 102
  • [9] IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM'S MACROGLOBULINEMIA (WM)
    Coutre, S.
    Leonard, J.
    Flowers, C.
    Davies, A.
    Jurczak, W.
    Byrd, J.
    Spurgeon, S.
    Peterman, S.
    Holes, L.
    Cho, Y.
    Sorenson, B.
    Godfrey, W.
    Gopal, A.
    HAEMATOLOGICA, 2015, 100 : 273 - 273
  • [10] A Phase 2 Study of Idelalisib Monotherapy in Previously Untreated Patients ≥65 Years with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
    Zelenetz, Andrew D.
    Lamanna, Nicole
    Kipps, Thomas J.
    Coutre, Steven E.
    O'Brien, Susan
    Aiello, Maria
    Cho, Yoonjin
    Dubowy, Ronald L.
    Flinn, Ian W.
    BLOOD, 2014, 124 (21)
12345